This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Depomed, Inc.. Active years: 2004-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2017
Title: Innovator Jong Lim: Pioneering Dual Drug Dosage Forms
Introduction
Jong Lim, an accomplished inventor based in San Jose, CA, has made significant contributions to the pharmaceutical industry. With four patents to his name, Lim has focused on the development of innovative drug formulations that enhance the effectiveness and safety of medication delivery. His expertise is instrumental in addressing the complexities associated with multi-drug therapies.
Latest Patents
One of Jong Lim's latest innovations is a dual drug dosage form featuring improved separation of drugs. This groundbreaking invention encompasses drug tablets that are designed with a prolonged-release core and an immediate-release layer or shell. A thin barrier layer composed of drug-free polymer is positioned between the prolonged-release and immediate-release segments of the tablet. This barrier layer is engineered to allow gastrointestinal fluid to access the prolonged-release core fully while maintaining integrity during the application of the immediate-release layer. As a result, it substantially reduces or eliminates any unwanted penetration of the immediate-release drug into the prolonged-release portion, thereby optimizing therapeutic outcomes.
Career Highlights
Jong Lim is currently associated with Depomed, Inc., a company known for its focus on developing specialized pharmaceuticals. His role at Depomed allows him to collaborate closely with fellow innovators in the field. Through his persistent commitment to research and development, Lim has emerged as a respected figure in pharmaceutical advancements.
Collaborations
Throughout his career, Jong Lim has worked alongside talented colleagues such as John N Shell and Jenny Louie-Helm. Their collaborative efforts have enabled the exploration of various innovative solutions within the realm of drug development. Successful teamwork is often a catalyst for impactful inventions, and Lim's partnerships illustrate the importance of collaboration in the pursuit of innovation.
Conclusion
In summary, Jong Lim is a dedicated inventor who continues to push the boundaries of pharmaceutical innovation. With four patents to his credit and a focus on dual drug dosage forms, he is paving the way for safer and more effective medication delivery systems. His collaborations with talented coworkers further enhance his contributions to the biotechnology landscape, solidifying his reputation as an influential figure in the pursuit of improved health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
